Why has Signant Health's eCOA solution seen a 15% drop in user engagement over the past month?

Introduction

Signant Health's eCOA (electronic Clinical Outcome Assessment) solution has experienced a 15% drop in user engagement over the past month, raising concerns about the product's performance and user satisfaction. This analysis will systematically investigate potential root causes, generate data-driven hypotheses, and propose a strategic plan to address the issue while considering both immediate and long-term implications.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a seasonal effect. Has this drop coincided with any particular events or time of year that could affect clinical trials?

Why it matters: Seasonal factors could explain temporary engagement drops. Expected answer: No significant seasonal events noted. Impact on approach: If seasonal, we'd focus on cyclical engagement strategies.

• Considering user segments, I'm wondering if this drop is uniform across all user types. Have you noticed any differences in engagement between patients, clinicians, and study coordinators?

Why it matters: Different user groups may have distinct issues requiring targeted solutions. Expected answer: The drop is more pronounced among patients. Impact on approach: We'd prioritize patient-centric improvements and investigate patient-specific barriers.

• Regarding recent changes, I'm curious if there have been any updates to the eCOA platform in the last 1-2 months that might have affected user experience?

Why it matters: Recent changes could directly impact user engagement. Expected answer: A minor UI update was implemented 6 weeks ago. Impact on approach: We'd scrutinize the UI changes and their potential effects on usability.

• Thinking about external factors, has there been any shift in regulatory requirements or industry standards that might influence how users interact with eCOA solutions?

Why it matters: External pressures could force users to adopt different tools or processes. Expected answer: No significant regulatory changes noted. Impact on approach: If regulatory changes exist, we'd need to adapt our solution to new compliance standards.